# Figure 1 Conversion Notes

## Overview
Figure 1 demonstrates state-dependent changes in dSPN (direct pathway spiny projection neurons) excitability between LID on- and off-states. The data includes:
- **Somatic excitability**: Current injection protocols measuring rheobase and F-I relationships
- **Dendritic excitability**: Combined patch clamp + two-photon line scan imaging measuring calcium transients
- **Immunostaining**: Confocal images showing pERK and TH expression

## Data Structure

```
Figure 1/
├── Dendritic excitability/
│   ├── LID off-state/
│   ├── LID on-state/
│   └── LID on-state with SCH/
├── Immunostaining images (Fig. 1B)/
└── Somatic excitability/
    ├── LID off-state/
    ├── LID on-state/
    └── LID on-state with SCH/
```

## Experimental Protocols

### Somatic Excitability Protocol

**Methodology**: Whole-cell patch clamp recording in current clamp mode

> Somatic excitability data were generated by recording voltage changes in response to current injection steps that are 500 ms in duration.

**Current Steps**:
- Range: -120 pA to +300 pA
- Step size: 20 pA
- Duration: 500 ms each
- Total steps: 21 (from cell1-001 to cell1-021)

**Analysis**: F-I relationship curves and rheobase measurements

### Dendritic Excitability Protocol

**Methodology**: Combination of patch clamp electrophysiology and two-photon laser scanning microscopy (2PLSM)

> To assess dSPN dendritic excitability in on- and off-states, a combination of patch clamp electrophysiology and two-photon laser scanning microscopy (2PLSM) was used. Specifically, dSPNs in ex vivo brain slices from off- or on-state mice were patch clamped, filled with Ca2+-sensitive dye Fluo-4 and Ca2+-insensitive dye Alexa Fluor 568 (to visualize dendrites), **and injected with brief current steps (three 2 nA injections, 2 ms each, at 50 Hz)**.

**Stimulus Protocol**:
```
Current (nA)
  2 |   ___      ___      ___
    |  |   |    |   |    |   |
  0 |__|   |____|   |____|   |____
      <-2ms->    <-2ms->    <-2ms->
      <---20ms--><---20ms--->
```

**Physiological Rationale**:
- **Back-propagating action potentials (bAPs)**: Somatically delivered current steps evoke spikes that back-propagate into SPN dendrites
- **Calcium signaling**: bAPs trigger transient opening of voltage-dependent Ca2+ channels, producing measurable calcium transients
- **Dendritic excitability assessment**: Magnitude of Ca2+ signals serves as a surrogate estimate of dendritic depolarization extent

**Analysis**:
- Ca2+ signals measured at proximal (~40 μm from soma) and distal (~90 μm from soma) dendritic locations
- **Distal/proximal ratio**: Used as index of dendritic excitability, normalized for experimental variables (dye concentration, laser intensity)
- **Significance**: Higher ratio indicates greater dendritic excitability and more effective bAP invasion

**Key Finding**: Dendritic excitability index significantly greater in on-state dSPNs than in off-state dSPNs (p = 0.0115)

## Data Organization

### Somatic Excitability Data Structure

**Directory Structure**:
```
LID on-state/
├── 04112019_1/     # Date + cell number
│   ├── cell1-001/  # -120 pA injection
│   ├── cell1-002/  # -100 pA injection
│   ├── cell1-003/  # -80 pA injection
│   ...
│   └── cell1-021/  # +300 pA injection
├── 04122019_1/
├── 05012019_1/
...
```

**File Bundle per Current Level**:
```
cell1-001/
├── cell1-001_Cycle00001_VoltageOutput_001.xml       # Stimulus protocol
├── cell1-001_Cycle00001_VoltageRecording_001.csv    # Voltage recording
├── cell1-001_Cycle00001_VoltageRecording_001.xml    # Recording metadata
├── cell1-001.xml                                    # Experiment metadata
└── References/                                      # Calibration files
```

### Dendritic Excitability Data Structure

**Raw Data Location**: `/home/heberto/development/surmeier-lab-to-nwb/link_to_raw_data/Figure 1/Dendritic excitability/`

**Naming Convention**: `[date]_Cell[cell number]_[location][location number]_trio-[trial number]`

Example: `07062017_Cell1_dist1_trio-001`

**Complete Directory Structure**:
```
Figure 1/Dendritic excitability/
├── LID off-state/
│   ├── 0202a/          # Feb 2nd, 2017, animal "a"
│   │   ├── 0202a1/     # Cell 1 from animal "a"
│   │   └── 0202a2/     # Cell 2 from animal "a"
│   ├── 0203a/          # Feb 3rd, 2017, animal "a"
│   │   ├── 0203a1/, 0203a2/, 0203a3/
│   ├── 0203c/          # Feb 3rd, 2017, animal "c"
│   │   ├── 0203c1/, 0203c2/
│   ├── 0204a/          # Feb 4th, 2017, animal "a"
│   │   ├── 0204a1/, 0204a2/
│   ├── 0204b/          # Feb 4th, 2017, animal "b"
│   │   ├── 0204b1/, 0204b2/
│   ├── 0812c/          # Aug 12th, 2016, animal "c"
│   │   └── 0812c1/
│   ├── 1111b/          # Nov 11th, 2016, animal "b"
│   │   ├── 1111b1/, 1111b2/
│   ├── 1111c/          # Nov 11th, 2016, animal "c"
│   │   └── 1111c2/
│   ├── 1114a/          # Nov 14th, 2016, animal "a"
│   │   ├── 1111a1/, 1111a2/, 1111a3/
│   └── 1116c/          # Nov 16th, 2016, animal "c"
│       ├── 1116c1/, 1116c2/
├── LID on-state/
│   ├── 0706a/          # July 6th, 2017, animal "a"
│   │   ├── 0706a1/, 0706a2/
│   ├── 0706b/          # July 6th, 2017, animal "b"
│   │   └── 0706b1/
│   ├── 0707a/          # July 7th, 2017, animal "a"
│   │   ├── 0707a1/, 0707a2/
│   ├── 0707b/          # July 7th, 2017, animal "b"
│   │   └── [Recording folders with detailed file structures]
│   ├── 0719a/          # July 19th, 2017, animal "a"
│   │   ├── 0719a1/, 0719a2/
│   ├── 0719b/          # July 19th, 2017, animal "b"
│   │   ├── 0719b1/, 0719b2/
│   ├── 0720a/          # July 20th, 2017, animal "a"
│   │   └── 0720a1/
│   ├── 0720b/          # July 20th, 2017, animal "b"
│   │   ├── 0720b1/, 0720b2/
│   ├── 0721a/          # July 21st, 2017, animal "a"
│   │   ├── 0721a1/, 0721a2/
│   └── 0721b/          # July 21st, 2017, animal "b"
│       ├── 0721b1/, 0721b2/
└── LID on-state with SCH/
    ├── 0411a2/         # April 11th, 2019, animal "a", cell 2
    ├── 0411b1/         # April 11th, 2019, animal "b", cell 1
    ├── 0412a/          # April 12th, 2019, animal "a"
    │   ├── 0412a1/, 0412a2/
    ├── 0412b/          # April 12th, 2019, animal "b"
    │   ├── 0412b1/, 0412b2/
    ├── 0501b/          # May 1st, 2019, animal "b"
    │   ├── 0501b1/, 0501b2/
    ├── 0503a3/         # May 3rd, 2019, animal "a", cell 3
    ├── 0503c/          # May 3rd, 2019, animal "c"
    ├── 0507b1/         # May 7th, 2019, animal "b", cell 1
    └── 0507c/          # May 7th, 2019, animal "c"
```

**Data Volume Summary**:
- **LID off-state**: 585M total data
- **LID on-state**: 525M total data
- **LID on-state with SCH**: 353M total data
- **Total**: 1.5GB of dendritic excitability data

**File Bundle per Recording**:
```
07062017_Cell1_dist1_trio-001/
├── *_Cycle00001_Ch1_000001.ome.tif          # Fluo-4 calcium channel kymograph
├── *-Cycle00001_Ch1Source.tif               # Field of view with scan line overlay
├── *_Cycle00001_Ch2_000001.ome.tif          # Alexa Fluor 568 structural channel
├── *-Cycle00001_Ch2Source.tif               # Structural channel field of view
├── *_Cycle00001_LineProfileData.csv         # Averaged fluorescence traces
├── *_Cycle00001_VoltageOutput_001.xml       # Stimulus protocol definition
├── *_Cycle00001_VoltageRecording_001.csv    # Raw electrophysiology data
├── *_Cycle00001_VoltageRecording_001.xml    # Recording metadata
├── *.env                                    # Environment configuration
├── *.xml                                    # Master experiment file
└── References/                              # Calibration files
```

## Key Metadata

### Line Scan Geometry (from .env files)
```xml
<LineScanController>
  <StraightLine XStart="0.3047" XStop="0.8000" Y="0.6328"/>
</LineScanController>
```
- Coordinates are normalized (0-1) defining scan line in field of view

### Profile Window Definition
```xml
<LineScanProfiles DataFile="..._LineProfileData.csv">
  <Profile number="1" channel="1" x0="0" x1="16"/>
  <Profile number="2" channel="2" x0="0" x1="16"/>
</LineScanProfiles>
```

### Stimulus Parameters (from VoltageOutput XML)
```json
"WaveformComponent_PulseTrain": {
    "Name": "Theta burst",
    "PulseCount": "3",
    "PulseWidth": "2",
    "PulseSpacing": "18",
    "PulsePotentialStart": "5",
    "PulsePotentialDelta": "0",
    "RestPotential": "0",
    "FirstPulseDelay": "900",
    "Repetitions": "1",
    "DelayBetweenReps": "158"
}
```

**Parameter Interpretation**:
- **PulseCount**: 3 → Three current injections
- **PulseWidth**: 2 ms → Each injection lasts 2 ms
- **PulseSpacing**: 18 ms → 18 ms between pulse starts (16 ms gap + 2 ms pulse = ~55 Hz)
- **PulsePotentialStart**: 5 → With UnitScaleFactor 400 and Units "pA" = 2000 pA = 2 nA
- **FirstPulseDelay**: 900 ms → Stimulus starts 900 ms after recording begins

## Channel Assignments

### Two-Photon Imaging Channels
- **Channel 1 (Ch1)**: Fluo-4 calcium-sensitive dye (green, 490-560 nm)
- **Channel 2 (Ch2)**: Alexa Fluor 568 structural dye (red, 580-620 nm)

### Kymograph Structure
- **Dimensions**: (C, T, X) where C=channels, T=time/lines, X=pixels along scan line
- **Typical size**: 2 channels × 2500 time points × 64 pixels per line

## Acquisition Parameters

### Electrophysiology
> All the electrophysiological recordings were made using a MultiClamp 700B amplifier (Axon Instrument, USA), and signals were filtered at 2 kHz and digitized at 10 kHz. Voltage protocols and data acquisition were performed by PrairieView 5.3 (Bruker).

### Two-Photon Imaging
> The recorded SPN was visualized using 810 nm excitation laser (Chameleon Ultra II, Coherent, Santa Clara, USA). Dendritic structure was visualized by the red signal of Alexa Fluor 568 detected by a Hamamatsu R3982 side-on photomultiplier tube (PMT, 580-620 nm). Calcium transients, as signals in the green channel, were detected by a Hamamatsu H7422P-40 GaAsP PMT (490-560 nm, Hamamatsu Photonics, Japan).

**Line Scan Parameters**:
- **Pixels per line**: 64
- **Dwell time**: 10 μs/pixel
- **Typical acquisition**: 2500 lines (time points)
- **Temporal resolution**: ~640 μs per line (64 pixels × 10 μs/pixel)
- **Total recording duration**: ~1.6 seconds for 2500 lines

**Imaging Strategy**:
- **Dendritic targeting**: Line scans positioned along dendrites at specific distances from soma
- **Dual-channel acquisition**: Simultaneous recording of calcium (Fluo-4) and structural (Alexa Fluor 568) signals
- **Spatial calibration**: Distances measured from soma to scan locations using structural channel
- **Signal validation**: Structural channel confirms dendrite integrity throughout recording

## Experimental Subjects and Procedures

*Sources: Information compiled from Zhai et al. 2025 paper (surmeier_article_bioarxiv.txt), Key Resources Table (Key resources table_Zhai_v1.xlsx), and protocols.io assets (assets/protocols/ folder)*

### Subject Information

**Animal Characteristics:**
- **Species**: Mus musculus (laboratory mice) *(Paper: Methods section)*
- **Strain**: C57BL/6 (C57Bl/6) background *(Paper: "Male C57Bl/6 hemizygous mice")*
- **Age**: 7-12 weeks old (ISO format: P7W/P12W) *(Paper: "(7-12 weeks of age)" in Methods)*
- **Sex**: Male mice exclusively *(Paper: "Male C57Bl/6 hemizygous mice")*
- **Genotypes**: *(Key Resources Table)*
  - **Drd1-Tdtomato BAC transgenic** (MMRRC_030512-UNC) - Direct pathway SPN identification
  - **Drd2-eGFP BAC transgenic** (MMRRC_000230-UNC) - Indirect pathway SPN identification
  - **Adora2-Cre mice** (MMRRC 031168-UCD) - Used for confocal microscopy studies
  - **CDGI knockout mice** (C57BL/6J background, generated at MIT) - For specific experiments

**Subject Selection Criteria:**
- Hemizygous for BAC transgenes, back-crossed to C57BL/6 background *(Paper: Methods)*
- Standard laboratory housing conditions
- Healthy animals with no visible abnormalities

### Surgical Procedures and LID Model Induction

#### 6-OHDA Lesioning Surgery

*Source: Protocol "Unilateral_6-hydroxydopamine_lesion_mouse_model_of_Parkinson_disease.md"*

**Pre-surgical Preparation:**
- **Anesthesia**: Isoflurane (5% induction, 2% maintenance with oxygen)
- **Analgesia**: Meloxicam (METACAM®, 0.1 mg/kg, s.c.)
- **Temperature control**: 37°C using temperature controller (ATC1000, World Precision Instruments)
- **Equipment**: David Kopf Instruments stereotaxic frame (Model 940)

**Surgical Protocol:**
1. **Site preparation**: Shaving, disinfection with 70% ethanol and iodine
2. **Skull exposure**: Small incision, tissue removal, skull leveling (Bregma-Lambda <0.05 mm)
3. **Stereotaxic coordinates** for medial forebrain bundle (MFB):
   - **Anteroposterior**: -0.7 mm from Bregma
   - **Mediolateral**: -1.2 mm from Bregma
   - **Dorsoventral**: -4.75 mm from dura surface

**6-OHDA Injection:**
- **Solution**: 3.5 mg/ml 6-OHDA hydrochloride (Sigma H4381) in saline + 0.02% L-ascorbic acid
- **Volume**: 1 μl delivered at <0.5 μl/min using calibrated glass micropipette
- **Timing**: 2-minute pre-injection wait, 10-minute post-injection wait before removal

**Post-operative Care:**
- Wound closure with surgical suture, lidocaine cream application
- Saline injection (0.5 ml sterile saline i.p.) for hydration
- Recovery on heating pad until conscious, then clean home cage
- **Recovery support**: Heating pad for 2 weeks, daily saline injections and dietary supplements for 2-3 weeks

#### Lesion Validation - Cylinder Test

*Source: Paper Methods section - "Three to four weeks after surgery"*

**Timeline**: 3-4 weeks post-surgery
**Procedure**: Drug-free forelimb-use asymmetry assessment
- **Duration**: 3 minutes in 500 ml beaker
- **Measurement**: Weight-bearing touches by left and right forepaws
- **Inclusion criterion**: <25% right paw touches (indicates near-complete lesion)

#### L-DOPA Treatment and Dyskinesia Induction

*Source: Paper Methods section and "Rating_of_levodopa-induced_dyskinesia_in_6-OHDA_lesioned_mice.md" protocol*

**Treatment Schedule:**
- **Timeline**: Within 1-7 days after cylinder test validation
- **Frequency**: Every other day for minimum 5 sessions *(Paper: "every other day for at least five sessions")*
- **Dosing regimen**: *(Paper: Methods)*
  - Sessions 1-2: 6 mg/kg L-DOPA + 12 mg/kg benserazide
  - Sessions 3-5+: 12 mg/kg L-DOPA + 12 mg/kg benserazide
- **Administration**: Intraperitoneal injection, fresh solutions used within 40 minutes

**Behavioral Assessment (AIM Scoring):**
- **Duration**: 2 hours post-L-DOPA injection *(AIM scoring protocol)*
- **Intervals**: Every 20 minutes (20, 40, 60, 80, 100, 120 min post-injection) *(AIM scoring protocol)*
- **Categories**: Axial, limb, and orolingual abnormal involuntary movements *(AIM scoring protocol)*
- **Scale**: 0-4 per category (half-scores permitted) *(AIM scoring protocol)*
- **Documentation**: Continuous video recording for all sessions

### Brain Slice Preparation

*Source: Paper Methods section and "Perfusion_and_fixation_of_brain_tissue_for_fresh_frozen_sections_followed_by_immunofluorescence_staining.md" protocol*

#### Experimental State Definition

**Off-State Slices:** *(Paper: "off-state mice were sacrificed 24-48 h after the last levodopa dose")*
- Mice sacrificed 24-48 hours after last L-DOPA dose
- Represents baseline dyskinetic state without acute L-DOPA effects

**On-State Slices:** *(Paper: "on-state mice were sacrificed 30 min after the last levodopa dose")*
- Mice sacrificed 30 minutes after final L-DOPA dose
- Represents peak dyskinetic state with elevated striatal phospho-ERK

#### Slice Preparation Protocol

*Source: Paper Methods section*

**Anesthesia and Perfusion:**
1. **Deep anesthesia**: Ketamine (100 mg/kg) + xylazine (7 mg/kg) mixture
2. **Transcardial perfusion**: Ice-cold sucrose-based cutting solution

**Cutting Solution Composition (mM):** *(Paper: Methods)*
- 181 sucrose, 25 NaHCO₃, 1.25 NaH₂PO₄, 2.5 KCl
- 0.5 CaCl₂, 7 MgCl₂, 11.6 sodium ascorbate, 3.1 sodium pyruvate, 5 glucose
- **Osmolarity**: 305 mOsm/l
- **Oxygenation**: Continuous carbogen (95% CO₂/5% O₂) bubbling

**Sectioning Parameters:** *(Paper: Methods)*
- **Equipment**: Leica VT1200 vibratome
- **Orientation**: Sagittal sections
- **Thickness**: 280 μm
- **Recovery**: 30 minutes at 34°C, then room temperature storage until recording

### Recording Conditions

*Source: Paper Methods section*

#### Artificial Cerebrospinal Fluid (ACSF)

**Standard ACSF Composition (mM):** *(Paper: Methods)*
- 124 NaCl, 3 KCl, 1 NaH₂PO₄, 2.0 CaCl₂, 1.0 MgCl₂, 26 NaHCO₃, 13.89 glucose
- **Temperature**: 31-32°C during recordings *(Paper: Methods)*
- **Flow rate**: 2-3 ml/min continuous superfusion *(Paper: Methods)*
- **Oxygenation**: Continuous carbogen (95% CO₂/5% O₂) bubbling *(Paper: Methods)*

#### Patch Pipette Solutions

*Source: Paper Methods section*

**Current-Clamp Internal Solution (mM):**
- 115 K-gluconate, 20 KCl, 1.5 MgCl₂, 5 HEPES, 0.2 EGTA
- 2 Mg-ATP, 0.5 Na-GTP, 10 Na-phosphocreatine
- **pH**: 7.25, **Osmolarity**: 280-290 mOsm/L

**Voltage-Clamp Internal Solution (mM):**
- 120 CsMeSO₃, 5 NaCl, 0.25 EGTA, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10 TEA, 5 QX-314
- **pH**: 7.25, **Osmolarity**: 280-290 mOsm/L

#### Imaging Solutions (for Dendritic Excitability)

*Source: Paper Methods section*

**Calcium Indicator:**
- **Fluo-4** (Thermo Fisher F14200): 100 μM concentration *(Paper: "100 μM Fluo-4")*
- **Function**: Ca²⁺-sensitive dye for calcium transient detection

**Morphological Dye:**
- **Alexa Fluor 568 hydrazide** (Thermo Fisher A10437): 50 μM concentration *(Paper: "50 μM Alexa Fluor 568")*
- **Function**: Ca²⁺-insensitive structural visualization of dendrites *(Paper: "to visualize dendrites")*

**Equilibration**: Minimum 15 minutes before imaging to ensure dye distribution

## Experimental Timeline Analysis

Based on timestamp analysis from the raw data, the experimental sequence follows this pattern:

| Time | Experiment | Location |
|------|------------|----------|
| 14:58:20 | Cell1_prox1_trio-001 | Proximal dendrite, trial 1 |
| 14:58:33 | Cell1_prox1_trio-002 | Proximal dendrite, trial 2 |
| 14:58:46 | Cell1_prox1_trio-003 | Proximal dendrite, trial 3 |
| 15:00:26 | Cell1_dist1_trio-001 | Distal dendrite, trial 1 |
| 15:00:42 | Cell1_dist1_trio-002 | Distal dendrite, trial 2 |
| 15:01:06 | Cell1_dist1_trio-003 | Distal dendrite, trial 3 |

**Pattern**: 3 trials at proximal location, then 3 trials at distal location, with ~13-24 second intervals between trials.

## Related Files
- [Overview](../conversion_notes_overview.md)
- [Figure 3 Notes](figure_3_conversion_notes.md) - Similar experimental design
